Astrea Bioseparations Acquires Delta Precision Ltd.

Astrea Bioseparations (Cambridge, UK) has announced the acquisition of Delta Precision Ltd. (Stonehouse, UK), a manufacturer of chromatography columns for the biotechnology and pharmaceutical industries. This acquisition will allow Astrea Bioseparations to expand its product offering to include a range of high-performance chromatography columns for biomanufacturing, alongside the company’s existing portfolio of bioprocessing resins, reusable columns, and prepacked single-use columns.

“We are delighted to welcome the Delta team into the fold. The acquisition of Delta is another step forward in Astrea Bioseparations’ rapid expansion to support the biopharmaceutical manufacturing field,” said Terry Pizzie, CEO of Astrea Bioseparations.

Geoff Parnell, co-founder and MD at Delta Precision, commented, “We look forward to joining the Astrea Bioseparations family, further cementing the long-standing relationship between the two companies. We are confident that our expertise in column manufacturing will complement and accelerate the Astrea Bioseparations business and customer reach.”

For more information, please visit: www.astreabioseparations.com or
www.delta-precision.co.uk